pancan.ai/Ask
Recruiting phase 3 KRAS trials
1,168 trials match; 50 of those shown are recruiting or about to. NCT07656376↗ NCT07619521↗ NCT07898813↗ NCT04381130↗ NCT07839676↗ NCT07905131↗ +44 more below
Computed from the knowledge API (findTrials); every record links to its source.
| Trial | Phase | Outcome | Status | Start | Sponsor |
|---|---|---|---|---|---|
| NCT07656376↗ Clinical Trial of DN022150 Combined With AG Chemotherapy as First-line Treatment for Locally Advanc… | Phase 2 / Phase 3 | Ongoing | Not yet recruiting | 2027-06 | Jiangxi Kvvit Pharmaceutical Co., Ltd. |
| NCT07619521↗ Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), fo… | Phase 1 / Phase 2 | Ongoing | Recruiting | 2027-06 | National Cancer Institute (NCI) |
| NCT07898813↗ Daraxonrasib in Resectable PDAC | Phase 1 | Ongoing | Not yet recruiting | 2027-04 | Dana-Farber Cancer Institute |
| NCT04381130↗ A Phase I/IIa Study of EF-009 in Patients With Pancreatic Cancer | Phase 1 / Phase 2 | Ongoing | Not yet recruiting | 2027-04 | Everfront Biotech Co., Ltd. |